1,2-Methylenedioxy-8-(2-p-methoxy-m-trifluoromethylphenyl-2-oxoethoxy)-9-methoxycycloberberine bromide

ID: ALA4162035

Chembl Id: CHEMBL4162035

PubChem CID: 145958462

Max Phase: Preclinical

Molecular Formula: C31H23BrF3NO6

Molecular Weight: 562.52

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(C(=O)COc2c(OC)ccc3c2c[n+]2c4c3ccc3c5c(cc(c34)CC2)OCO5)cc1C(F)(F)F.[Br-]

Standard InChI:  InChI=1S/C31H23F3NO6.BrH/c1-37-24-7-3-16(11-22(24)31(32,33)34)23(36)14-39-30-21-13-35-10-9-17-12-26-29(41-15-40-26)20-5-4-19(28(35)27(17)20)18(21)6-8-25(30)38-2;/h3-8,11-13H,9-10,14-15H2,1-2H3;1H/q+1;/p-1

Standard InChI Key:  LLLNLPJBMLKLKG-UHFFFAOYSA-M

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus saprophyticus (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.52Molecular Weight (Monoisotopic): 562.1472AlogP: 6.02#Rotatable Bonds: 6
Polar Surface Area: 67.10Molecular Species: NEUTRALHBA: 6HBD: 0
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: CX LogP: 1.11CX LogD: 1.11
Aromatic Rings: 5Heavy Atoms: 41QED Weighted: 0.14Np Likeness Score: 0.40

References

1. Fan T, Hu X, Tang S, Liu X, Wang Y, Deng H, You X, Jiang J, Li Y, Song D..  (2018)  Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA.,  (5): [PMID:29795764] [10.1021/acsmedchemlett.8b00094]

Source